ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,382Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 393

$567K Total Retail Price of All Prescriptions

Rank: 47 out of 393

888 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 888 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 888 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 11,579 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 881 835 1 1
LEVOTHYROXINE SODIUM 759 710 2 3
OMEPRAZOLE 635 587 3 6
LISINOPRIL 584 553 4 2
HYDROCODONE-ACETAMINOPHEN 533 463 S3 5 5
ATENOLOL 378 359 6 13
LOSARTAN POTASSIUM 368 355 7 12
LOVASTATIN 328 318 8 14
AMLODIPINE BESYLATE 305 290 9 4
HYDROCHLOROTHIAZIDE 291 278 10 10
ALENDRONATE SODIUM 284 283 11 16
METFORMIN HCL 227 218 12 7
METOPROLOL TARTRATE 221 213 13 9
TRIAMTERENE-HCTZ 210 201 14 49
ZOLPIDEM TARTRATE 190 176 15 11
CIPROFLOXACIN HCL 160 152 16 57
FUROSEMIDE 159 152 17 8
BENAZEPRIL HCL 151 151 18 40
POTASSIUM CHLORIDE 143 130 19 20
WARFARIN SODIUM 143 135 19 17
GABAPENTIN 124 117 21 15
PAROXETINE HCL 119 108 22 61
TAMSULOSIN HCL 117 112 23 25
TRAMADOL HCL 112 106 24 30
FLUTICASONE PROPIONATE 111 102 25 27
ATORVASTATIN CALCIUM 109 104 26 19
AZITHROMYCIN 96 90 27 35
SERTRALINE HCL 95 78 28 28
ALLOPURINOL 92 92 29 26
JANUVIA 87 86 30 87
METOPROLOL SUCCINATE 84 70 31 22
PRAVASTATIN SODIUM 75 75 32 18
CARVEDILOL 72 71 33 21
CITALOPRAM HBR 72 72 33 23
GLYBURIDE 70 68 R 35 46
RANITIDINE HCL 67 62 36 29
GEMFIBROZIL 66 64 37 62
DIGOXIN 66 61 37 66
AMOX TR-POTASSIUM CLAVULANATE 65 55 39 100
ISOSORBIDE MONONITRATE ER 64 62 40 67
DOXAZOSIN MESYLATE 62 62 41 83
DILTIAZEM 24HR CD 61 61 42 152
TRIAMTERENE-HYDROCHLOROTHIAZID 61 59 42 273
METHYLPREDNISOLONE 60 58 44 80
LANTUS SOLOSTAR 59 59 45 74
FINASTERIDE 59 59 45 60
AMITRIPTYLINE HCL 57 40 R 47 72
GLIPIZIDE 56 50 48 32
CLOPIDOGREL 55 55 49 33
PREDNISONE 54 54 50 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 54 50 24
FLUOXETINE HCL 52 50 52 37
TRIAMCINOLONE ACETONIDE 52 50 52 94
TIZANIDINE HCL 50 45 54 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.